Extensive Endoscopic Image-Guided Sinus Surgery Decreases BPI-ANCA in Patients with Cystic Fibrosis

Scandinavian Journal of Immunology

Volumn 76, Issue 6, 2012, Pages 573-579

  Aanaes, K ^a   Rasmussen, N ^a,b   Pressler, T ^a   Segelmark, M ^c   Johansen, H K ^a   Lindberg, U ^d   Hoiby N ^a   Carlsson, M ^d   Wieslander, J ^e   Buchwald, C ^a  

^a International Center for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health   (Denmark)

^b STATENS SERUM INSTITUT   (Denmark)

^c LINKÖPING UNIVERSITY   (Sweden)

^d LUND UNIVERSITY   (Sweden)

^e EuroDiagnostica AB   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERICIDAL PERMEABILITY INCREASING PROTEIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; NEUTROPHIL CYTOPLASMIC ANTIBODY;

ACHROMOBACTER XYLOSOXIDANS INFECTION; ADOLESCENT; ADULT; ARTICLE; BACTERIAL INFECTION; BURKHOLDERIA CEPACIA INFECTION; CHILD; CYSTIC FIBROSIS; ENDOSCOPIC SINUS SURGERY; EXTENSIVE IMAGE GUIDED SINUS SURGERY; FEMALE; HUMAN; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PSEUDOMONAS INFECTION; SCHOOL CHILD;

ADOLESCENT; ADULT; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; ANTIBODIES, BACTERIAL; ANTIMICROBIAL CATIONIC PEPTIDES; BIOLOGICAL MARKERS; BLOOD PROTEINS; CHILD; CYSTIC FIBROSIS; ENDOSCOPY; FEMALE; HUMANS; IMMUNOMODULATION; MALE; MIDDLE AGED; PARANASAL SINUSES; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; SURGERY, COMPUTER-ASSISTED; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84869009678     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2012.02775.x     Document Type: Article

References (29)

1. Hansen SK, Rau MH, Johansen HK et al. Evolution and diversification of Pseudomonas aeruginosa in the paranasal sinuses of cystic fibrosis children have implications for chronic lung infection. ISME J 2012;6:31-45.
2. Rasmussen J, Aanæs K, Norling R, Nielsen KG, Johansen HK, von Buchwald C. CT of the paranasal sinuses is not a valid indicator for sinus surgery in CF patients. J Cyst Fibros 2012;11:93-9.
3. Johansen HK, Aanaes K, Pressler T et al. Colonisation and infection of the paranasal sinuses in cystic fibrosis patients is accompanied by a reduced PMN response. J Cyst Fibros 2012. May 15. [Epub ahead of print].
4. Lachenal F, Nkana K, Nove-Josserand R, Fabien N, Durieu I. Prevalence and clinical significance of auto-antibodies in adults with cystic fibrosis. Eur Respir J 2009;34:1079-85.
5. Carlsson M, Eriksson L, Pressler T et al. Autoantibody response to BPI predict disease severity and outcome in cystic fibrosis. J Cyst Fibros 2007;6:228-33.
6. Carlsson M, Eriksson L, Erwander I, Wieslander J, Segelmark M. Pseudomonas-induced lung damage in cystic fibrosis correlates to bactericidal-permeability increasing protein (BPI)-autoantibodies. Clin Exp Rheumatol 2003;21:S95-100.
7. Dorlochter L, Carlsson M, Olafsdottir EJ, Roksund OD, Rosendahl K, Fluge G. Anti-neutrophil cytoplasmatic antibodies and lung disease in cystic fibrosis. J Cyst Fibros 2004;3:179-83.
8. Schultz H, Weiss JP. The bactericidal/permeability-increasing protein (BPI) in infection and inflammatory disease. Clin Chim Acta 2007;384:12-23.
9. Schultz H. From infection to autoimmunity: a new model for induction of ANCA against the bactericidal/permeability increasing protein (BPI). Autoimmun Rev 2007;6:223-7.
10. Thomas M, Yawn BP, Price D, Lund V, Mullol J, Fokkens W. EPOS Primary Care Guidelines: European Position Paper on the Primary Care Diagnosis and Management of Rhinosinusitis and Nasal Polyps. Prim Care Respir J 2008;17:79-89.
11. Lee TW, Brownlee KG, Conway SP, Denton M, Littlewood JM. Evaluation of a new definition for chronic Pseudomonas aeruginosa infection in cystic fibrosis patients. J Cyst Fibros 2003;2:29-34.
12. Knudsen PK, Olesen HV, Hoiby N et al. Differences in prevalence and treatment of Pseudomonas aeruginosa in cystic fibrosis centres in Denmark, Norway and Sweden. J Cyst Fibros 2009;8:135-42.
13. Hoiby N, Frederiksen B. Microbiology of cystic fibrosis. In: Hodson ME, Geddes DM, eds. Cystic Fibrosis. London: Arnold, 2000:83-107.
14. Johansen HK, Norregaard L, Gotzsche PC, Pressler T, Koch C, Hoiby N. Antibody response to Pseudomonas aeruginosa in cystic fibrosis patients: a marker of therapeutic success?-A 30-year cohort study of survival in Danish CF patients after onset of chronic P. aeruginosa lung infection. Pediatr Pulmonol 2004;37:427-32.
15. Hoiby N, Frederiksen B, Pressler T. Eradication of early Pseudomonas aeruginosa infection. J Cyst Fibros 2005;4 (Suppl 2):49-54.
16. Aanaes K, Johansen HK, Skov M et al. Clinical effects of sinus surgery - a one year prospective follow-up study of 106 patients with cystic fibrosis. Abstract 291 in Pediatr Pulmonol 2012 (Suppl 35).
17. Elborn JS, Cordon SM, Shale DJ. Host inflammatory responses to first isolation of Pseudomonas aeruginosa from sputum in cystic fibrosis. Pediatr Pulmonol 1993;15:287-91.
18. Frederiksen B, Koch C, Hoiby N. Antibiotic treatment of initial colonization with Pseudomonas aeruginosa postpones chronic infection and prevents deterioration of pulmonary function in cystic fibrosis. Pediatr Pulmonol 1997;23:330-5.
19. Tiddens HA. Detecting early structural lung damage in cystic fibrosis. Pediatr Pulmonol 2002;34:228-31.
20. Bjarnsholt T, Jensen PO, Fiandaca MJ et al. Pseudomonas aeruginosa biofilms in the respiratory tract of cystic fibrosis patients. Pediatr Pulmonol 2009;44:547-58.
21. Van der Woude FJ, Rasmussen N, Lobatto S et al. Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis. Lancet 1985;1:425-9.
22. Csernok E, Holle J, Hellmich B et al. Evaluation of capture ELISA for detection of antineutrophil cytoplasmic antibodies directed against proteinase 3 in Wegener's granulomatosis: first results from a multicentre study. Rheumatology (Oxford) 2004;43:174-80.
23. Kain R, Exner M, Brandes R et al. Molecular mimicry in pauci-immune focal necrotizing glomerulonephritis. Nat Med 2008;14:1088-96.
24. Pendergraft WF III, Pressler BM, Jennette JC, Falk RJ, Preston GA. Autoantigen complementarity: a new theory implicating complementary proteins as initiators of autoimmune disease. J Mol Med (Berl) 2005;83:12-25.
25. Ciavatta DJ, Yang J, Preston GA et al. Epigenetic basis for aberrant upregulation of autoantigen genes in humans with ANCA vasculitis. J Clin Invest 2010;120:3209-19.
26. Falk RJ, Terrell RS, Charles LA, Jennette JC. Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro. Proc Natl Acad Sci USA 1990;87:4115-19.
27. Little MA, Smyth CL, Yadav R et al. Antineutrophil cytoplasm antibodies directed against myeloperoxidase augment leukocyte-microvascular interactions in vivo. Blood 2005;106:2050-8.
28. Little MA, Al-Ani B, Ren S et al. Anti-proteinase 3 anti-neutrophil cytoplasm autoantibodies recapitulate systemic vasculitis in mice with a humanized immune system. PLoS ONE 2012;7:e28626.
29. Kerem E, Conway S, Elborn S, Heijerman H. Standards of care for patients with cystic fibrosis: a European consensus. J Cyst Fibros 2005;4:7-26.